SUBSCRIBE
SUBSCRIBE
News   Business   Deals

Drug Company DiObex, Inc. Shutting Down

April 8, 2009 | 
1 min read
Private Equity Hub -- DiObex Inc., a San Francisco-based drug company focused on metabolic disorders like Type II diabetes, has laid off all its employees and is looking to sell its assets, according to VentureWire.
Bankruptcy
MORE ON THIS TOPIC
A piggy bank crammed with $100 bills on a background of American cash
Deals
Biohaven could get up to $795M in epilepsy alliance with SK Bio
August 26, 2026
 · 
2 min read
 · 
Tristan Manalac
Words IPO (Initial public offering) with the trading data on the background.
IPO
2026 IPO stock tracker: How newly public biotechs are performing
August 26, 2026
 · 
1 min read
 · 
Gabrielle Masson
Illustration of cardboard box filled with office supplies, a computer keyboard, lamp, and a potted plant
Layoff Tracker
Cellares cuts jobs after losing pharma customer
August 25, 2026
 · 
86 min read
 · 
BioSpace Editorial Staff
Creative light bulb explodes with colorful paint splashes and shards of glass on a black background. Think differently creative idea concept. Dry paint splatter. Brainstorm and think
Deals
China’s Haisco forms immunology biotech with up to $1.5B from American VCs
August 25, 2026
 · 
1 min read
 · 
Annalee Armstrong